William Blair analyst Mylers Minter reiterated an Outperform rating on Dianthus Therapeutics (NASDAQ: DNTH)The analyst commented, "We continue to be ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments